Sulfur hexafluoride lipid microsphere
Sulfur hexafluoride lipid microsphere is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| lumason | New Drug Application | 2025-07-22 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
Code | Description |
|---|---|
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml |
Clinical
Clinical Trials
221 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Liver neoplasms | D008113 | EFO_1001513 | C22.0 | 1 | 2 | 4 | 1 | 12 | 20 |
| Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | 1 | 1 | 1 | 10 | 14 |
| Retinal perforations | D012167 | EFO_1001028 | — | 1 | — | — | 1 | 10 | 12 |
| Abdominal injuries | D000007 | — | — | 2 | 2 | — | 3 | 1 | 6 |
| Wounds and injuries | D014947 | — | T14.8 | 1 | 1 | — | 2 | 2 | 5 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | — | 2 | — | 1 | 1 | 4 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | — | — | 1 | 3 | 4 |
| Infarction | D007238 | EFO_0009463 | — | — | 1 | — | 1 | 2 | 4 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | — | — | — | 1 | 3 | 4 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | — | 1 | — | 1 | 1 | 3 |
Show 7 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Retinal detachment | D012163 | EFO_0005773 | H33.2 | — | 1 | 1 | — | 14 | 16 |
| Neoplasms | D009369 | — | C80 | 2 | 2 | 1 | — | 5 | 8 |
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | 1 | — | 1 | — | 5 | 7 |
| Stroke | D020521 | EFO_0000712 | I63.9 | 1 | 1 | 2 | — | 3 | 7 |
| Prostatic neoplasms | D011471 | — | C61 | — | — | 1 | — | 6 | 7 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | 1 | 1 | — | 2 | 6 |
| Carotid stenosis | D016893 | — | — | — | 1 | 1 | — | 3 | 5 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 2 | 1 | 1 | — | 1 | 4 |
| Glioblastoma | D005909 | EFO_0000515 | — | 2 | 1 | 1 | — | 1 | 4 |
| Glioma | D005910 | EFO_0000520 | — | 2 | 1 | 1 | — | 1 | 4 |
Show 22 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Carcinoma | D002277 | — | C80.0 | — | 1 | — | — | 8 | 9 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | 2 | — | — | 4 | 6 |
| Colorectal neoplasms | D015179 | — | — | 1 | 2 | — | — | 3 | 5 |
| Adenocarcinoma | D000230 | — | — | — | 1 | — | — | 3 | 4 |
| Kidney transplantation | D016030 | — | — | 1 | 1 | — | — | 2 | 4 |
| Kidney neoplasms | D007680 | EFO_0003865 | C64 | — | 2 | — | — | 1 | 3 |
| Chronic renal insufficiency | D051436 | — | N18 | — | 1 | — | — | 2 | 3 |
| Ultrasonography | D014463 | — | — | — | 1 | — | — | 2 | 3 |
| Anterior wall myocardial infarction | D056988 | EFO_1000812 | — | — | 1 | — | — | 1 | 2 |
| Portal hypertension | D006975 | EFO_0000666 | K76.6 | — | 1 | — | — | 1 | 2 |
Show 16 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Fibrosis | D005355 | — | — | 1 | — | — | — | 3 | 4 |
| Asthma | D001249 | EFO_0000270 | J45 | 1 | — | — | — | 2 | 3 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | — | — | — | 1 | 2 |
| Acute kidney injury | D058186 | — | N17 | 1 | — | — | — | 1 | 2 |
| Delayed graft function | D051799 | — | — | 1 | — | — | — | 1 | 2 |
| Pulmonary embolism | D011655 | EFO_0003827 | I26 | 1 | — | — | — | — | 1 |
| Lung neoplasms | D008175 | — | C34.90 | 1 | — | — | — | — | 1 |
| Obstructive sleep apnea | D020181 | EFO_0003918 | G47.33 | 1 | — | — | — | — | 1 |
| Lung transplantation | D016040 | — | — | 1 | — | — | — | — | 1 |
| Cystic fibrosis | D003550 | EFO_0000390 | E84 | 1 | — | — | — | — | 1 |
Show 20 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dissociative disorders | D004213 | — | F44.1 | — | — | — | — | 8 | 8 |
| Fuchs' endothelial dystrophy | D005642 | EFO_0003946 | H18.51 | — | — | — | — | 4 | 4 |
| Microcirculation | D008833 | — | — | — | — | — | — | 4 | 4 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | — | — | 3 | 3 |
| Vitrectomy | D014821 | — | — | — | — | — | — | 3 | 3 |
| Carotid artery diseases | D002340 | EFO_0003781 | — | — | — | — | — | 3 | 3 |
| Vision disorders | D014786 | — | H53.11 | — | — | — | — | 2 | 2 |
| Hereditary corneal dystrophies | D003317 | — | H18.5 | — | — | — | — | 2 | 2 |
| Cataract | D002386 | EFO_0001059 | H26.9 | — | — | — | — | 2 | 2 |
| Colonic neoplasms | D003110 | — | C18 | — | — | — | — | 2 | 2 |
Show 104 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Sulfur hexafluoride lipid microsphere |
| INN | — |
| Description | Sulfur hexafluoride lipid microsphere is an unknown pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL3545306 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
Black-box warning for: Lumason
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
1,826 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use